[Microbial population of lower respiratory tract in children from different age groups with cystic fibrosis]

Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|March 12, 2010
PubMed

Insights

Chronic lower respiratory tract infections are common in children with cystic fibrosis, with infections increasing with age. Understanding these microbial patterns is key to preventing future complications.

Area of Science:

  • Medical Microbiology
  • Pediatric Pulmonology
  • Infectious Diseases

Background:

  • Cystic fibrosis (CF) is a genetic disorder affecting multiple organs, particularly the lungs.
  • Chronic respiratory infections are a major cause of morbidity and mortality in CF patients.
  • Understanding the dynamic microflora of the lower respiratory tract is crucial for managing CF.

Purpose of the Study:

  • To investigate the variability of lower respiratory tract microflora in children with cystic fibrosis (CF).
  • To identify potential sources of infectious complications in pediatric CF patients.
  • To analyze the progression of microbial colonization with age in CF patients.

Main Methods:

  • Analysis of 141 medical histories of CF patients across different age groups and regions.
  • Prospective follow-up of 84 pediatric CF patients in Moscow and surrounding regions.
  • Utilized microbiological, molecular biological, and statistical methods for microorganism identification and characterization.

Main Results:

  • Chronic Pseudomonas, staphylococcal, or mixed infections were present in 25% of 1-4 year olds and 80% of 18-year-olds.
  • Microorganism associations (3-5 microbes) were found in 60% of hospitalized patients.
  • Beyond Pseudomonas aeruginosa and Staphylococcus aureus, Gram-negative nonfermentative bacteria like Burkholderia cepacia were frequently identified.

Conclusions:

  • Chronic mixed infections are a hallmark of cystic fibrosis respiratory disease.
  • Identifying mechanisms of lung infection in CF is essential for developing evidence-based prevention strategies.
  • Targeted interventions can mitigate infectious complications in pediatric CF patients.
Abstract

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...